Development and validation of DNA Methylation scores in two European cohorts augment 10-year risk prediction of type 2 diabetes
View ORCID ProfileYipeng Cheng, View ORCID ProfileDanni A Gadd, View ORCID ProfileChristian Gieger, View ORCID ProfileKarla Monterrubio-Gómez, Yufei Zhang, Imrich Berta, View ORCID ProfileMichael J Stam, Natalia Szlachetka, Evgenii Lobzaev, Nicola Wrobel, View ORCID ProfileLee Murphy, View ORCID ProfileArchie Campbell, View ORCID ProfileCliff Nangle, View ORCID ProfileRosie M Walker, View ORCID ProfileChloe Fawns-Ritchie, View ORCID ProfileAnnette Peters, View ORCID ProfileWolfgang Rathmann, View ORCID ProfileDavid J Porteous, View ORCID ProfileKathryn L Evans, View ORCID ProfileAndrew M McIntosh, View ORCID ProfileTimothy I Cannings, View ORCID ProfileMelanie Waldenberger, View ORCID ProfileAndrea Ganna, View ORCID ProfileDaniel L McCartney, View ORCID ProfileCatalina A Vallejos, View ORCID ProfileRiccardo E Marioni
doi: https://doi.org/10.1101/2021.11.19.21266469
Yipeng Cheng
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
2Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
Danni A Gadd
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Christian Gieger
3Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
5German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Karla Monterrubio-Gómez
6MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Yufei Zhang
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Imrich Berta
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Michael J Stam
7School of Informatics, University of Edinburgh, Edinburgh, EH8 9AB, UK
Natalia Szlachetka
7School of Informatics, University of Edinburgh, Edinburgh, EH8 9AB, UK
Evgenii Lobzaev
7School of Informatics, University of Edinburgh, Edinburgh, EH8 9AB, UK
Nicola Wrobel
8Edinburgh Clinical Research Facility, University of Edinburgh, Western General Hospital, Edinburgh, UK
Lee Murphy
8Edinburgh Clinical Research Facility, University of Edinburgh, Western General Hospital, Edinburgh, UK
Archie Campbell
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Cliff Nangle
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Rosie M Walker
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
9Centre for Clinical Brain Sciences, University of Edinburgh, Chancellor’s Building, 49 Little France Crescent, Edinburgh BioQuarter, Edinburgh, EH16 4SB, UK
Chloe Fawns-Ritchie
10Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Annette Peters
4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
5German Center for Diabetes Research (DZD), München-Neuherberg, Germany
11DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Wolfgang Rathmann
12Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
5German Center for Diabetes Research (DZD), München-Neuherberg, Germany
David J Porteous
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Kathryn L Evans
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Andrew M McIntosh
13Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
Timothy I Cannings
14School of Mathematics, University of Edinburgh, Edinburgh, EH9 3FD, UK
Melanie Waldenberger
3Research Unit Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
Andrea Ganna
2Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
Daniel L McCartney
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Catalina A Vallejos
6MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
15The Alan Turing Institute, London, UK
Riccardo E Marioni
1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Article usage
Posted August 01, 2022.
Development and validation of DNA Methylation scores in two European cohorts augment 10-year risk prediction of type 2 diabetes
Yipeng Cheng, Danni A Gadd, Christian Gieger, Karla Monterrubio-Gómez, Yufei Zhang, Imrich Berta, Michael J Stam, Natalia Szlachetka, Evgenii Lobzaev, Nicola Wrobel, Lee Murphy, Archie Campbell, Cliff Nangle, Rosie M Walker, Chloe Fawns-Ritchie, Annette Peters, Wolfgang Rathmann, David J Porteous, Kathryn L Evans, Andrew M McIntosh, Timothy I Cannings, Melanie Waldenberger, Andrea Ganna, Daniel L McCartney, Catalina A Vallejos, Riccardo E Marioni
medRxiv 2021.11.19.21266469; doi: https://doi.org/10.1101/2021.11.19.21266469
Development and validation of DNA Methylation scores in two European cohorts augment 10-year risk prediction of type 2 diabetes
Yipeng Cheng, Danni A Gadd, Christian Gieger, Karla Monterrubio-Gómez, Yufei Zhang, Imrich Berta, Michael J Stam, Natalia Szlachetka, Evgenii Lobzaev, Nicola Wrobel, Lee Murphy, Archie Campbell, Cliff Nangle, Rosie M Walker, Chloe Fawns-Ritchie, Annette Peters, Wolfgang Rathmann, David J Porteous, Kathryn L Evans, Andrew M McIntosh, Timothy I Cannings, Melanie Waldenberger, Andrea Ganna, Daniel L McCartney, Catalina A Vallejos, Riccardo E Marioni
medRxiv 2021.11.19.21266469; doi: https://doi.org/10.1101/2021.11.19.21266469
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)